Literature DB >> 31582003

The Diagnosis and Management of Neurofibromatosis Type 1.

K Ina Ly1, Jaishri O Blakeley2.   

Abstract

Neurofibromatosis type 1 (NF1), NF2, and schwannomatosis are related, but distinct, tumor suppressor syndromes characterized by a predilection for tumors in the central and peripheral nervous systems. NF1 is one of the most common autosomal dominant conditions of the nervous system. NF1 has a high degree of variability in clinical presentation, which may include multiple neoplasms as well as cutaneous, vascular, bony, and cognitive features. Some of these manifestations overlap with other genetic conditions. Accurate diagnosis of NF1 is important for individualizing clinical care and genetic counseling. This article summarizes the clinical features, diagnostic work-up, and management of NF1.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cutaneous neurofibroma; Nervous system; Neurofibromatosis type 1; Plexiform neurofibroma; RASopathy; Tumor predisposition syndrome

Mesh:

Year:  2019        PMID: 31582003     DOI: 10.1016/j.mcna.2019.07.004

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  27 in total

1.  Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome.

Authors:  Tomoko Kaneyasu; Seiichi Mori; Hideko Yamauchi; Shozo Ohsumi; Shinji Ohno; Daisuke Aoki; Shinichi Baba; Junko Kawano; Yoshio Miki; Naomichi Matsumoto; Masao Nagasaki; Reiko Yoshida; Sadako Akashi-Tanaka; Takuji Iwase; Dai Kitagawa; Kenta Masuda; Akira Hirasawa; Masami Arai; Junko Takei; Yoshimi Ide; Osamu Gotoh; Noriko Yaguchi; Mitsuyo Nishi; Keika Kaneko; Yumi Matsuyama; Megumi Okawa; Misato Suzuki; Aya Nezu; Shiro Yokoyama; Sayuri Amino; Mayuko Inuzuka; Tetsuo Noda; Seigo Nakamura
Journal:  NPJ Breast Cancer       Date:  2020-06-12

2.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

Review 3.  An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies.

Authors:  Jae-Sung Yi; Sravan Perla; Anton M Bennett
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-14       Impact factor: 3.727

Review 4.  Skin sonography in children: a review.

Authors:  Cristian Garcia; Ximena Wortsman; Diego Bazaes-Nuñez; Mario Pelizzari; Sergio Gonzalez; Maria-Laura Cossio; Florencia De Barbieri
Journal:  Pediatr Radiol       Date:  2022-07-12

5.  Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques.

Authors:  Rafay Ahmed; Sasidhar Uppuganti; Shrey Derasari; Joshua Meyer; Jacquelyn S Pennings; Florent Elefteriou; Jeffry S Nyman
Journal:  J Bone Miner Res       Date:  2022-07-12       Impact factor: 6.390

Review 6.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

7.  Potential markers of disease behavior in acromegaly and gigantism.

Authors:  Laura C Hernández-Ramírez
Journal:  Expert Rev Endocrinol Metab       Date:  2020-05-06

8.  Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.

Authors:  Gaku Tsuji; Ayako Takai-Yumine; Takahiro Kato; Masutaka Furue
Journal:  Cell Death Dis       Date:  2021-05-19       Impact factor: 8.469

Review 9.  The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors.

Authors:  Yiyang Zheng; Yanyan Luo; Xixi Chen; Huiting Li; Baojun Huang; Baofeng Zhou; Liqing Zhu; Xianhui Kang; Wujun Geng
Journal:  Mol Cancer       Date:  2021-03-05       Impact factor: 27.401

10.  Renal manifestations in children with neurofibromatosis type 1.

Authors:  Binnaz Celik; Ozlem Yuksel Aksoy; Funda Bastug; Hatice Gamze Poyrazoglu
Journal:  Eur J Pediatr       Date:  2021-06-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.